We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
+8.34%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$2.32B
AUM Growth
+$160M
Cap. Flow
-$125M
Cap. Flow %
-5.36%
Top 10 Hldgs %
55.17%
Holding
93
New
22
Increased
20
Reduced
17
Closed
23

Sector Composition

Rank Sector Weight
1 Miscellaneous 45.29%
2 Healthcare 36.08%
3 Consumer Discretionary 10.58%
4 Financials 3.02%
5 Industrials 2.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$894M
$463M 19.93%
57,517,978
-3
-0% -$22
WW
2
DELISTED
WW International
WW
$143M 6.15%
29,443,300
BIIB icon
3
CALL
Biogen
BIIB
$31.9B
$141M 6.09%
350,000
+115,000
+49% +$46.2M
WMT icon
4
CALL
Walmart Inc
WMT
$858B
$118M 5.08%
4,995,000
+4,095,000
+455% +$104M
GOOG icon
5
CALL
Alphabet (Google) Class C
GOOG
$4.18T
$117M 5.04%
+4,500,000
New +$121M
CELG
6
CALL
DELISTED
Celgene Corp
CELG
$69.4M 2.99%
600,000
+300,000
+100% +$34.3M
GS icon
7
CALL
Goldman Sachs
GS
$284B
$62.6M 2.7%
300,000
+200,000
+200% +$40.8M
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$12.5B
$59.5M 2.56%
435,000
-45,000
-9% -$5.58M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$31.9B
$54.5M 2.35%
455,000
-15,000
-3% -$1.79M
GE icon
10
CALL
GE Aerospace
GE
$319B
$53.1M 2.29%
417,324
+208,662
+100% +$27.1M
INCY icon
11
Incyte
INCY
$24.7B
$50M 2.15%
480,000
-30,000
-6% -$3.11M
YUM icon
12
CALL
Yum! Brands
YUM
$38.4B
$45M 1.94%
695,500
-278,200
-29% -$17.6M
BAC icon
13
CALL
Bank of America
BAC
$416B
$42.5M 1.83%
2,500,000
-2,500,000
-50% -$41.2M
BABA icon
14
Alibaba
BABA
$272B
$41.1M 1.77%
500,000
-75,000
-13% -$6.45M
JPM icon
15
CALL
JPMorgan Chase
JPM
$937B
$40.7M 1.75%
600,000
-300,000
-33% -$19.6M
MA icon
16
Mastercard
MA
$502B
$37.4M 1.61%
400,000
+50,000
+14% +$4.59M
AXP icon
17
CALL
American Express
AXP
$219B
$35M 1.51%
+450,000
New +$35.7M
BLUE
18
DELISTED
bluebird bio
BLUE
$33.7M 1.45%
15,440
-11,580
-43% -$23.6M
MET icon
19
CALL
MetLife
MET
$62.4B
$33.6M 1.45%
673,200
-561,000
-45% -$26.6M
GM icon
20
CALL
General Motors
GM
$74.9B
$33.3M 1.43%
+1,000,000
New +$35.7M
QCOM icon
21
CALL
Qualcomm
QCOM
$201B
$31.3M 1.35%
+500,000
New +$34.1M
MS icon
22
CALL
Morgan Stanley
MS
$324B
$29.1M 1.25%
+750,000
New +$28.5M
MRK icon
23
CALL
Merck
MRK
$355B
$28.5M 1.23%
524,000
-1,257,600
-71% -$70.5M
AMZN icon
24
Amazon
AMZN
$2.68T
$28.2M 1.21%
1,300,000
+300,000
+30% +$6.27M
BMRN icon
25
CALL
BioMarin Pharmaceuticals
BMRN
$12.5B
$27.4M 1.18%
200,000

Similar funds

Artal Group's Q2 2015 Portfolio in Review

As of Q2 2015, Artal Group held 93 positions worth $2.32B, up 7.4% from $2.16B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Artal Group withdrew a net $125M in Q2 2015, closing 23 positions and reducing 17 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $48.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 45% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Artal Group opened a new position in American Airlines Group worth $16M.

  • Artal Group's largest Q2 2015 buy was American Airlines Group: 400,000 shares worth $16M.
  • Artal Group added most to Happen Inc in Q2 2015, an estimated $10.3M increase.
  • Artal Group's biggest Q2 2015 reduction was bluebird bio, cutting an estimated $23.6M.
  • Artal Group fully exited Alphabet (Google) Class C in Q2 2015, selling an estimated $48.4M.
  • Artal Group's ten largest holdings make up 55% of its $2.32B portfolio in Q2 2015.
  • Artal Group opened 22 new positions and closed 23 in Q2 2015.
  • Artal Group's portfolio value rose 7.4% quarter-over-quarter to $2.32B.

Based on Artal Group's 13F filing for Q2 2015, filed 13 Aug 2015.